Drug Trial Radar · NCT02953340
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Last checked: Nov 20, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
237
Actual
Start
May 10, 2017
Primary completion
Jun 8, 2018
Study completion May 6, 2019
Sponsor
- Lead sponsor
- Spectrum Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- First posted
- Nov 2, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of SPI-2012 versus pegfilgrastim in participants with early-stage breast cancer receiving docetaxel and cyclophosphamide (TC) as measured by the duration of severe neutropenia (DSN).
Conditions
- Neutropenia
- Breast Cancer
Interventions
SPI-2012Drug
Supplied in prefilled single-use syringes for subcutaneous injection, administered on Day 2 of each cycle
PegfilgrastimDrug
Subcutaneous injection administered on Day 2 of each cycle.
DocetaxelDrug
75mg/m\^2 IV infusion administered on Day 1 of each cycle
CyclophosphamideDrug
600mg/m\^2 IV infusion administered on Day 1 of each cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Duration of Severe Neutropenia (DSN) in Cycle 1Time frame: Day 1 and daily on Days 4-15 in Cycle 1 (each cycle = 21 days)
Locations
74 sites in 6 countries. Site status is shown where the registry gives one.
ACRC/ Arizona Clinical Research Center Inc.
Tucson, Arizona
Yuma Regional Cancer Center
Yuma, Arizona
Genesis Cancer Center
Hot Springs, Arkansas
NEA Baptist Clinic | Fowler Family Center for Cancer Care
Jonesboro, Arkansas
Pacific Cancer Medical Center, Inc.
Anaheim, California
Compassionate Care Research Group, Inc.
Fountain Valley, California
California Cancer Associates for Research and Excellence Inc.
Fresno, California
Pacific Shores Medical Group
Long Beach, California
Los Angeles Hematology Oncology Medical Group
Los Angeles, California
Desert Regional Medical Center
Palm Springs, California
Emad Ibrahim, MD, INC.
Redlands, California
Innovative Clinical Research Institute/ The Oncology Institute of Hope and Innovation
Whittier, California
Denver Health & Hospital Authority
Denver, Colorado
Pasco Pinellas Cancer Center
Holiday, Florida
Lakes Research, LLC
Miami Lakes, Florida
Mid-Florida Hematology and Oncology Centers
Orange City, Florida
Millennium Oncology
Pembroke Pines, Florida
BRCR Medical Center Inc
Plantation, Florida
Pinellas Hematology and Oncology
St. Petersburg, Florida
Bond & Steele Clinic, PA.
Winter Haven, Florida
John B. Amos Cancer Center
Columbus, Georgia
Cancer Center of Middle Georgia
Dublin, Georgia
Dwight D. Eisenhower Army Medical Center
Fort Gordon, Georgia
Saint Alphonsus Regional Medical Center
Boise, Idaho
Oncology Specialists, SC
Park Ridge, Illinois
FPN Oncology and Hematology Specialists
Indianapolis, Indiana
Commonwealth Hematology-Oncology, PSC
Danville, Kentucky
Pontchartrain Cancer Center
Covington, Louisiana
Quest Research Institute
Royal Oak, Michigan
Coborn Cancer Center
Saint Cloud, Minnesota
Hattiesburg Clinic Hematology/Oncology
Hattiesburg, Mississippi
Freeman Health Systems
Joplin, Missouri
St. Vincent Frontier Cancer Center
Billings, Montana
CHI Health St Francis, St Francis Cancer Treatment Center
Grand Island, Nebraska
Waverly Hematology Oncology
Cary, North Carolina
Gaston Hematology & Oncology Associates, PC
Gastonia, North Carolina
Aultman Hospital
Canton, Ohio
The Christ Hospital Cancer Center
Cincinnati, Ohio
St. Elizabeth Youngstown Hospital JACBCC/Oncology/ Mercy Health Youngstown LLC
Youngstown, Ohio
Carolina Blood and Cancer Care Associates
Rock Hill, South Carolina
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.